Value of serum uric acid combined with Gensini score in predicting prognosis of patients with acute ST segment elevation myocardial infarction
-
摘要:目的 探讨血清尿酸联合Gensini积分对急性ST段抬高型心肌梗死(STEMI)患者经皮冠状动脉介入治疗(PCI)术后预后的预测价值。方法 选取408例行PCI治疗的STEMI患者作为研究对象,将术后发生主要不良心血管事件(MACE)的64例患者纳入观察组,将未发生MACE的344例患者纳入对照组。比较2组患者的冠状动脉病变、血清尿酸水平、Gensini积分及其他生化指标。结果 观察组平均年龄、有糖尿病病史者占比、空腹血糖水平、血清尿酸水平、Gensini评分均高于对照组,差异有统计学意义(P < 0.05)。年龄、糖尿病病史、血清尿酸、Gensini评分均为PCI术后发生MACE的独立影响因素(P < 0.05)。血清尿酸联合Gensini评分对MACE的预测敏感性、特异性高于血清尿酸、Gensini评分,差异有统计学意义(P < 0.05)。结论 血清尿酸、Gensini积分均与STEMI患者PCI术后预后密切相关,两者联用可有效预测MACE发生风险。
-
关键词:
- 血清尿酸 /
- Gensini积分 /
- 心肌梗死 /
- 经皮冠状动脉介入治疗 /
- 预后
Abstract:Objective To investigate the value of serum uric acid combined with Gensini score in predicting prognosis of patients with acute ST segment elevation myocardial infarction (STEMI) after percutaneous coronary intervention (PCI).Methods A total of 408 STEMI patients treated with PCI were selected as study objects, among whom 64 cases with Major Adverse Cardiovascular Events (MACE) were included in observation group, and 344 cases without MACE were included in the control group. Coronary artery lesions, serum uric acid, Gensini score and other biochemical indexes were compared between the two groups.Results The average age, the proportion of patients with history of diabetes, fasting blood glucose, serum uric acid and Gensini scores in the observation group were significantly higher than those in the control group (P < 0.05). Age, history of diabetes, serum uric acid and Gensini score were independent influencing factors of MACE after PCI (P < 0.05). The sensitivity and specificity of serum uric acid and Gensini score in combination in predicting MACE were significantly higher than those of serum uric acid and Gensini score(P < 0.05).Conclusion Serum uric acid and Gensini score are closely related to the prognosis of STEMI patients after PCI. The combination of the two indexes can effectively predict the risk of MACE. -
-
表 1 2组患者一般资料比较(x±s)[n(%)]
指标 观察组(n=64) 对照组(n=344) 性别 男 40(62.50) 201(58.43) 女 24(37.50) 143(41.57) 年龄/岁 68.88±6.01* 63.05±7.24 BMI/(kg/m2) 24.86±1.30 24.71±1.17 饮酒史 28(43.75) 164(47.67) 吸烟史 38(59.38) 205(59.59) 病史 心肌梗死 4(6.25) 23(6.69) 高血压病 32(50.00) 165(47.97) 糖尿病 25(39.06)* 51(14.83) BMI: 体质量指数。与对照组比较, *P < 0.05。 表 2 2组患者生化指标水平比较(x±s)
指标 观察组(n=64) 对照组(n=344) FBG/(mmol/L) 10.03±1.86* 8.41±1.90 TC/(mmol/L) 1.65±0.70 1.58±0.32 TG/(mmol/L) 4.50±0.45 4.43±0.41 LDL-C/(mmol/L) 2.47±0.42 2.56±0.69 HDL-C/(mmol/L) 0.87±0.31 0.90±0.35 cTnI/(μg/L) 152.84±32.69 153.18±35.12 FBG: 空腹血糖; TC: 总胆固醇; TG: 甘油三酯;
LDL-C: 低密度脂蛋白胆固醇; HDL-C: 高密度脂蛋白胆固醇;
cTnI: 肌钙蛋白I。与对照组比较, *P < 0.05。表 3 2组患者血清尿酸、Gensini评分比较(x±s)
组别 n 血清尿酸/(μmol/L) Gensini评分/分 对照组 344 347.60±64.36 63.16±18.73 观察组 64 422.39±85.77* 84.63±22.04* 与对照组比较, *P < 0.05。 表 4 PCI术后发生MACE的危险因素分析
因素 β SE Wald P OR 95%CI 年龄 0.050 0.014 5.319 0.025 1.133 1.062~1.419 糖尿病病史 1.505 0.528 5.671 0.015 4.663 2.014~12.720 FBG 0.135 0.537 0.092 0.901 1.315 0.370~4.221 血清尿酸 0.041 0.020 6.201 0.010 1.120 1.000~1.885 Gensini评分 0.032 0.018 6.354 0.009 1.084 1.024~1.922 FBG: 空腹血糖。 -
[1] 张云雁. 女性急性心肌梗死的特点研究进展[J]. 东南国防医药, 2018, 20(3): 276-280. doi: 10.3969/j.issn.1672-271X.2018.03.013 [2] 李龙, 谢翔. ST段抬高型急性心肌梗死合并多支血管病变经皮冠状动脉介入治疗方案选择研究进展[J]. 中华实用诊断与治疗杂志, 2018, 32(4): 395-398. [3] 梁云亮, 盖婉丽, 李森杰, 等. Ang1、Ang2与急性心肌梗死病人预后的关系探讨[J]. 中西医结合心脑血管病杂志, 2019, 17(9): 1343-1346. [4] 赖敏华, 李静芝, 陈凌, 等. 冠心病患者PCI术后全因死亡率、再入院率及其影响因素分析[J]. 实用医学杂志, 2020, 36(6): 801-807. doi: 10.3969/j.issn.1006-5725.2020.06.019 [5] 中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 急性ST段抬高型心肌梗死诊断和治疗指南[J]. 中华心血管病杂志, 2015, 43(5): 380-393. doi: 10.3760/cma.j.issn.0253-3758.2015.05.003 [6] GENSINI G G. A more meaningful scoring system for determining the severity of coronary heart disease[J]. Am J Cardiol, 1983, 51(3): 606. doi: 10.1016/S0002-9149(83)80105-2
[7] 闫洁, 袁森. 急性心肌梗死PCI术后近期MACE的危险因素及血小板功能参数的预测作用[J]. 中国动脉硬化杂志, 2020, 28(12): 58-65. [8] 吕赛, 周玉杰, 刘巍. 高尿酸血症、代谢综合征与冠心病的研究进展[J]. 心肺血管病杂志, 2018, 37(1): 76-78. doi: 10.3969/j.issn.1007-5062.2018.01.019 [9] 王小华, 王伟, 张妮. 血清脂蛋白(a)、尿酸及血浆同型半胱氨酸水平与冠心病、脑梗死的相关性分析[J]. 中西医结合心脑血管病杂志, 2019, 17(16): 2408-2411. doi: 10.12102/j.issn.1672-1349.2019.16.003 [10] 刘新民, 董建增, 刘小慧, 等. 无症状高尿酸血症对择期经皮冠状动脉介入治疗术后病死率的影响[J]. 中华医学杂志, 2017, 97(7): 508-511. doi: 10.3760/cma.j.issn.0376-2491.2017.07.007 [11] 贾金瑞, 于健. 急性心肌梗死患者血尿酸浓度、killip分级对死亡的预测价值[J]. 岭南心血管病杂志, 2018, 24(2): 146-149. doi: 10.3969/j.issn.1007-9688.2018.02.06 [12] 刘冰, 洪权, 冯哲. 高糖与高尿酸通过醛糖还原酶通路协同作用加重内皮细胞损伤[J]. 中华肾病研究电子杂志, 2018, 7(1): 34-38. doi: 10.3877/cma.j.issn.2095-3216.2018.01.008 [13] MAZIDI M, KATSIKI N, BANACH M. Α higher ratio of serum uric acid to serum creatinine could predict the risk of total and cause specific mortality- insight from a US national survey[J]. Int J Cardiol, 2021, 326: 189-193. doi: 10.1016/j.ijcard.2020.05.098
[14] 陈继舜, 刘晓唤, 钱航, 等. Gensini评分和HsCRP在预测PCI术后支架内再狭窄的价值[J]. 西安交通大学学报: 医学版, 2018, 39(3): 336-340. [15] 石鑫岳, 王静, 刘暘. 冠心病患者血尿酸与血脂和冠脉病变数量相关[J]. 基础医学与临床, 2019, 39(2): 245-246. doi: 10.3969/j.issn.1001-6325.2019.02.020